InvestorsHub Logo
Followers 8
Posts 739
Boards Moderated 0
Alias Born 08/26/2020

Re: Mymani post# 131910

Tuesday, 12/08/2020 12:28:17 AM

Tuesday, December 08, 2020 12:28:17 AM

Post# of 233049
Anyone have any thoughts about the following: The last placeholder code is very similar to Leronlimab's, and it's also listed as subcutaneous.


"Four specific substances classified as monoclonal antibodies– Bamlanivimab, Etesevimab, Leronlimab and REGN-COV2—have new PCS codes to track their use in treating COVID-19. Leronlimab is administered by subcutaneous injection, and the other three substances are administered via IV infusion.
...
XW013K6 Introduction of Leronlimab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
...
XW013H6 Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News